Compared to the p53 WT group, tumors with p53 missense and hotspot mutations demonstrated lower expression of p53 targets p21 and PUMA, but retained high YTHDF2 expression in LGG, GBM, BRCA and READ cancers (Fig. 7b and Supplementary Fig. 8a). This evidence concerns the gene BBC3 and glioblastoma.